BNP Paribas Financial Markets’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,776
| Closed | -$321K | – | 4271 |
|
|
2020
Q3 | $321K | Sell |
3,776
-35,250
| -90% | -$1.78M | ﹤0.01% | 2472 |
|
|
2020
Q2 | $1.38M | Sell |
39,026
-53,833
| -58% | -$1.57M | ﹤0.01% | 1652 |
|
|
2020
Q1 | $1.25M | Buy |
92,859
+67,827
| +271% | +$1.14M | ﹤0.01% | 1764 |
|
|
2019
Q4 | $530K | Sell |
25,032
-6,038
| -19% | -$107K | ﹤0.01% | 2417 |
|
|
2019
Q3 | $412K | Buy |
31,070
+10,610
| +52% | +$156K | ﹤0.01% | 2319 |
|
|
2019
Q2 | $284K | Sell |
20,460
-14,566
| -42% | -$219K | ﹤0.01% | 2378 |
|
|
2019
Q1 | $673K | Buy |
35,026
+31,200
| +815% | +$503K | ﹤0.01% | 1911 |
|
|
2018
Q4 | $54.6K | Sell |
3,826
-4,423
| -54% | -$87.8K | ﹤0.01% | 2675 |
|
|
2018
Q3 | $172K | Buy |
8,249
+844
| +11% | +$20K | ﹤0.01% | 2469 |
|
|
2018
Q2 | $175K | Sell |
7,405
-14,286
| -66% | -$287K | ﹤0.01% | 2506 |
|
|
2018
Q1 | $317K | Buy |
21,691
+222
| +1% | +$3.63K | ﹤0.01% | 2510 |
|
|
2017
Q4 | $347K | Buy |
21,469
+11,158
| +108% | +$132K | ﹤0.01% | 2691 |
|
|
2017
Q3 | $144K | Sell |
10,311
-710
| -6% | -$7.08K | ﹤0.01% | 2609 |
|
|
2017
Q2 | $97.3K | Buy |
11,021
+10,357
| +1,560% | +$72.7K | ﹤0.01% | 2839 |
|
|
2017
Q1 | $4.3K | Sell |
664
-4,917
| -88% | -$24.9K | ﹤0.01% | 3347 |
|
|
2016
Q4 | $20.5K | Sell |
5,581
-517
| -8% | -$1.53K | ﹤0.01% | 3174 |
|
|
2016
Q3 | $19.8K | Buy |
6,098
+2,546
| +72% | +$7.12K | ﹤0.01% | 2897 |
|
|
2016
Q2 | $8.24K | Buy |
+3,552
| New | +$11.9K | ﹤0.01% | 3006 |
|
|
2016
Q1 | – | Sell |
-19,366
| Closed | -$59.5K | – | 3271 |
|
|
2015
Q4 | $59.5K | Sell |
19,366
-3,158
| -14% | -$8.81K | ﹤0.01% | 2688 |
|
|
2015
Q3 | $38.7K | Buy |
22,524
+14,499
| +181% | +$37K | ﹤0.01% | 3042 |
|
|
2015
Q2 | $32.6K | Buy |
8,025
+6,077
| +312% | +$24.8K | ﹤0.01% | 2736 |
|
|
2015
Q1 | $7.46K | Buy |
+1,948
| New | +$8.47K | ﹤0.01% | 2919 |
|
|
2014
Q4 | – | Sell |
-4,866
| Closed | -$18.1K | – | 3525 |
|
|
2014
Q3 | $18.1K | Buy |
+4,866
| New | +$16.4K | ﹤0.01% | 3237 |
|
|
2014
Q2 | – | Sell |
-191
| Closed | -$804 | – | 4004 |
|
|
2014
Q1 | $804 | Sell |
191
-823
| -81% | -$4.08K | ﹤0.01% | 2927 |
|
|
2013
Q4 | $4.66K | Sell |
1,014
-19,186
| -95% | -$85.4K | ﹤0.01% | 3136 |
|
|
2013
Q3 | $125K | Sell |
20,200
-10,786
| -35% | -$62.1K | ﹤0.01% | 2379 |
|
|
2013
Q2 | $169K | Buy |
+30,986
| New | +$102K | ﹤0.01% | 2396 |
|
BNP Paribas Financial Markets's IMMU Position: Q4 2020 in Review
BNP Paribas Financial Markets sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,776 shares — an estimated $321K sold.
BNP Paribas Financial Markets first reported a position in IMMU in Q2 2013 and held it in 27 quarters. The position peaked at $1.38M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- BNP Paribas Financial Markets reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 3,776 Immunomedics Inc shares in Q4 2020, an estimated $321K.
- BNP Paribas Financial Markets first reported a position in Immunomedics Inc in Q2 2013 and held it in 27 quarters.
- BNP Paribas Financial Markets's Immunomedics Inc position peaked at $1.38M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.